Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish

Altered dopaminergic signaling causes behavioral changes in mammals. In general, dopaminergic receptor agonists increase locomotor activity, while antagonists decrease locomotor activity. In order to determine if zebrafish (a model organism becoming popular in pharmacology and toxicology) respond si...

Full description

Saved in:
Bibliographic Details
Published inPharmacology, biochemistry and behavior Vol. 103; no. 4; pp. 792 - 813
Main Authors Irons, T.D., Kelly, P.E., Hunter, D.L., MacPhail, R.C., Padilla, S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Altered dopaminergic signaling causes behavioral changes in mammals. In general, dopaminergic receptor agonists increase locomotor activity, while antagonists decrease locomotor activity. In order to determine if zebrafish (a model organism becoming popular in pharmacology and toxicology) respond similarly, the acute effects of drugs known to target dopaminergic receptors in mammals were assessed in zebrafish larvae. Larvae were maintained in 96-well microtiter plates (1 larva/well). Non-lethal concentrations (0.2–50μM) of dopaminergic agonists (apomorphine, SKF-38393, and quinpirole) and antagonists (butaclamol, SCH-23390, and haloperidol) were administered at 6days post-fertilization (dpf). An initial experiment identified the time of peak effect of each drug (20–260min post-dosing, depending on the drug). Locomotor activity was then assessed for 70min in alternating light and dark at the time of peak effect for each drug to delineate dose-dependent effects. All drugs altered larval locomotion in a dose-dependent manner. Both the D1- and D2-like selective agonists (SKF-38393 and quinpirole, respectively) increased activity, while the selective antagonists (SCH-23390 and haloperidol, respectively) decreased activity. Both selective antagonists also blunted the response of the larvae to changes in lighting conditions at higher doses. The nonselective drugs had biphasic effects on locomotor activity: apomorphine increased activity at the low dose and at high doses, while butaclamol increased activity at low to intermediate doses, and decreased activity at high doses. This study demonstrates that (1) larval zebrafish locomotion can be altered by dopamine receptor agonists and antagonists, (2) receptor agonists and antagonists generally have opposite effects, and (3) drugs that target dopaminergic receptors in mammals appear, in general, to elicit similar locomotor responses in zebrafish larvae. ► Larval locomotion was altered by dopamine receptor agonists and antagonists. ► Receptor agonists and antagonists generally had opposite effects. ► Larval zebrafish are promising models for dopamine behavioral pharmacology.
AbstractList Altered dopaminergic signaling causes behavioral changes in mammals. In general, dopaminergic receptor agonists increase locomotor activity, while antagonists decrease locomotor activity. In order to determine if zebrafish (a model organism becoming popular in pharmacology and toxicology) respond similarly, the acute effects of drugs known to target dopaminergic receptors in mammals were assessed in zebrafish larvae. Larvae were maintained in 96-well microtiter plates (1 larva/well). Non-lethal concentrations (0.2–50 µM) of dopaminergic agonists (apomorphine, SKF-38393, and quinpirole) and antagonists (butaclamol, SCH-23390, and haloperidol) were administered at 6 days post-fertilization (dpf). An initial experiment identified the time of peak effect of each drug (20–260 minutes post-dosing, depending on the drug). Locomotor activity was then assessed for 70 minutes in alternating light and dark at the time of peak effect for each drug to delineate dose-dependent effects. All drugs altered larval locomotion in a dose-dependent manner. Both the D1- and D2-like selective agonists (SKF-38393 and quinpirole, respectively) increased activity, while the selective antagonists (SCH-23390 and haloperidol, respectively) decreased activity. Both selective antagonists also blunted the response of the larvae to changes in lighting conditions at higher doses. The nonselective drugs had biphasic effects on locomotor activity: apomorphine increased activity at the low dose and at high doses, while butaclamol increased activity at low to intermediate doses, and decreased activity at high doses. This study demonstrates that (1) larval zebrafish locomotion can be altered by dopamine receptor agonists and antagonists, (2) receptor agonists and antagonists generally have opposite effects, and (3) drugs that target dopaminergic receptors in mammals appear, in general, to elicit similar locomotor responses in zebrafish larvae.
Altered dopaminergic signaling causes behavioral changes in mammals. In general, dopaminergic receptor agonists increase locomotor activity, while antagonists decrease locomotor activity. In order to determine if zebrafish (a model organism becoming popular in pharmacology and toxicology) respond similarly, the acute effects of drugs known to target dopaminergic receptors in mammals were assessed in zebrafish larvae. Larvae were maintained in 96-well microtiter plates (1 larva/well). Non-lethal concentrations (0.2-50 μM) of dopaminergic agonists (apomorphine, SKF-38393, and quinpirole) and antagonists (butaclamol, SCH-23390, and haloperidol) were administered at 6 days post-fertilization (dpf). An initial experiment identified the time of peak effect of each drug (20-260 min post-dosing, depending on the drug). Locomotor activity was then assessed for 70 min in alternating light and dark at the time of peak effect for each drug to delineate dose-dependent effects. All drugs altered larval locomotion in a dose-dependent manner. Both the D1- and D2-like selective agonists (SKF-38393 and quinpirole, respectively) increased activity, while the selective antagonists (SCH-23390 and haloperidol, respectively) decreased activity. Both selective antagonists also blunted the response of the larvae to changes in lighting conditions at higher doses. The nonselective drugs had biphasic effects on locomotor activity: apomorphine increased activity at the low dose and at high doses, while butaclamol increased activity at low to intermediate doses, and decreased activity at high doses. This study demonstrates that (1) larval zebrafish locomotion can be altered by dopamine receptor agonists and antagonists, (2) receptor agonists and antagonists generally have opposite effects, and (3) drugs that target dopaminergic receptors in mammals appear, in general, to elicit similar locomotor responses in zebrafish larvae.
Altered dopaminergic signaling causes behavioral changes in mammals. In general, dopaminergic receptor agonists increase locomotor activity, while antagonists decrease locomotor activity. In order to determine if zebrafish (a model organism becoming popular in pharmacology and toxicology) respond similarly, the acute effects of drugs known to target dopaminergic receptors in mammals were assessed in zebrafish larvae. Larvae were maintained in 96-well microtiter plates (1 larva/well). Non-lethal concentrations (0.2–50μM) of dopaminergic agonists (apomorphine, SKF-38393, and quinpirole) and antagonists (butaclamol, SCH-23390, and haloperidol) were administered at 6days post-fertilization (dpf). An initial experiment identified the time of peak effect of each drug (20–260min post-dosing, depending on the drug). Locomotor activity was then assessed for 70min in alternating light and dark at the time of peak effect for each drug to delineate dose-dependent effects. All drugs altered larval locomotion in a dose-dependent manner. Both the D1- and D2-like selective agonists (SKF-38393 and quinpirole, respectively) increased activity, while the selective antagonists (SCH-23390 and haloperidol, respectively) decreased activity. Both selective antagonists also blunted the response of the larvae to changes in lighting conditions at higher doses. The nonselective drugs had biphasic effects on locomotor activity: apomorphine increased activity at the low dose and at high doses, while butaclamol increased activity at low to intermediate doses, and decreased activity at high doses. This study demonstrates that (1) larval zebrafish locomotion can be altered by dopamine receptor agonists and antagonists, (2) receptor agonists and antagonists generally have opposite effects, and (3) drugs that target dopaminergic receptors in mammals appear, in general, to elicit similar locomotor responses in zebrafish larvae. ► Larval locomotion was altered by dopamine receptor agonists and antagonists. ► Receptor agonists and antagonists generally had opposite effects. ► Larval zebrafish are promising models for dopamine behavioral pharmacology.
Author Padilla, S.
Hunter, D.L.
MacPhail, R.C.
Kelly, P.E.
Irons, T.D.
AuthorAffiliation d Toxicology Assessment Division, National Health and Environmental Effects Laboratory, United States Environmental Protection Agency, Research Triangle Park, NC 27711
a Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
c Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
b Integrated Systems Toxicology Division, National Health and Environmental Effects Laboratory, United States Environmental Protection Agency, Research Triangle Park, NC 27711
AuthorAffiliation_xml – name: b Integrated Systems Toxicology Division, National Health and Environmental Effects Laboratory, United States Environmental Protection Agency, Research Triangle Park, NC 27711
– name: a Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
– name: c Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
– name: d Toxicology Assessment Division, National Health and Environmental Effects Laboratory, United States Environmental Protection Agency, Research Triangle Park, NC 27711
Author_xml – sequence: 1
  givenname: T.D.
  surname: Irons
  fullname: Irons, T.D.
  email: Terra.Irons@va.gov
  organization: Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 2
  givenname: P.E.
  surname: Kelly
  fullname: Kelly, P.E.
  organization: Department of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
– sequence: 3
  givenname: D.L.
  surname: Hunter
  fullname: Hunter, D.L.
  organization: Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, NC 27711, USA
– sequence: 4
  givenname: R.C.
  surname: MacPhail
  fullname: MacPhail, R.C.
  organization: Toxicology Assessment Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, NC 27711, USA
– sequence: 5
  givenname: S.
  surname: Padilla
  fullname: Padilla, S.
  organization: Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, United States Environmental Protection Agency, Research Triangle Park, NC 27711, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23274813$$D View this record in MEDLINE/PubMed
BookMark eNp9kNtKAzEQhoNU7EEfwBvZF9ia2ewmWwShFE9Q8EavQzaZtCntpiTbgj69qVXRG2Fgkpn5_0y-Iem1vkVCLoGOgQK_Xo23TTMuKBTjFBToCRlALVhegRA9MqB0AjmjleiTYYwrSmlZcHFG-gUrRFkDGxCc6l2HmTIb17rYBdU532beZsZvVaphWDidmbBbxGypYmactRiw7ZxaZ5jOuotZUqy99hv_KXbppsI-9d-xCcq6uDwnp1atI1585RF5vb97mT3m8-eHp9l0nuu0cZdbzjgvuKpsw4yxulIGCmMop0XNQU1qI3SDAqCqq3JSNwoqZKBLpkprG8HYiNwefbe7ZoNGpz2DWsttcBsV3qRXTv7ttG4pF34vGS9pzUQygKOBDj7GgPZHC1QemMuVTMzlgblMkZgnzdXvR38U35DTwM1xANPX9w6DjNphq9G4kPhJ490_9h9RcZdA
CitedBy_id crossref_primary_10_1186_s42238_023_00177_w
crossref_primary_10_1016_j_envpol_2018_06_013
crossref_primary_10_1016_j_chemosphere_2019_06_009
crossref_primary_10_1016_j_envpol_2016_03_048
crossref_primary_10_1016_j_ntt_2023_107183
crossref_primary_10_1074_jbc_M115_697466
crossref_primary_10_1016_j_neulet_2017_03_002
crossref_primary_10_1007_s00213_015_4030_y
crossref_primary_10_1016_j_pbb_2014_09_022
crossref_primary_10_1021_acs_est_8b04327
crossref_primary_10_1016_j_neuro_2015_11_012
crossref_primary_10_1016_j_chemosphere_2022_134691
crossref_primary_10_3389_fnmol_2022_900213
crossref_primary_10_1007_s11356_014_2676_3
crossref_primary_10_1016_j_bbr_2016_01_034
crossref_primary_10_1016_j_envpol_2018_10_129
crossref_primary_10_1016_j_pnpbp_2018_02_010
crossref_primary_10_1016_j_neubiorev_2024_105715
crossref_primary_10_1007_s00213_014_3656_5
crossref_primary_10_1007_s11356_014_3477_4
crossref_primary_10_1002_brb3_1420
crossref_primary_10_1289_EHP5843
crossref_primary_10_1186_s42238_021_00103_y
crossref_primary_10_1016_j_etap_2022_103885
crossref_primary_10_1016_j_scitotenv_2017_07_144
crossref_primary_10_1111_bph_13754
crossref_primary_10_3389_fphys_2022_1040598
crossref_primary_10_1016_j_aquatox_2018_08_001
crossref_primary_10_3390_ijms21175981
crossref_primary_10_1126_scitranslmed_abh3763
crossref_primary_10_1016_j_jes_2015_05_002
crossref_primary_10_1016_j_ntt_2018_03_002
crossref_primary_10_1016_j_pnpbp_2020_110179
crossref_primary_10_1016_j_taap_2021_115477
crossref_primary_10_1111_nmo_13006
crossref_primary_10_1016_j_alcohol_2015_08_003
crossref_primary_10_1016_j_pbb_2016_03_010
crossref_primary_10_1016_j_pnpbp_2018_12_012
crossref_primary_10_1021_acs_est_1c03457
crossref_primary_10_1371_journal_pone_0094227
crossref_primary_10_1002_bdr2_1180
crossref_primary_10_1016_j_chemosphere_2024_141851
crossref_primary_10_1016_j_neurobiolaging_2021_02_005
crossref_primary_10_1007_s11356_014_3805_8
crossref_primary_10_1007_s00213_022_06252_z
crossref_primary_10_1016_j_ejphar_2020_173489
crossref_primary_10_1016_j_ejphar_2021_174517
crossref_primary_10_3390_biomedicines7010023
crossref_primary_10_1089_zeb_2017_1468
crossref_primary_10_1038_s41598_020_66378_y
crossref_primary_10_1016_j_ecoenv_2020_111014
crossref_primary_10_3390_toxics11040353
crossref_primary_10_1016_j_envpol_2017_08_038
crossref_primary_10_1007_s11356_018_2127_7
crossref_primary_10_1016_j_neuro_2020_02_003
crossref_primary_10_1016_j_bbr_2018_08_028
crossref_primary_10_1038_s41598_017_03144_7
crossref_primary_10_47495_okufbed_1365490
crossref_primary_10_1016_j_jhazmat_2019_03_049
crossref_primary_10_1021_es4042258
crossref_primary_10_1177_02698811231166463
crossref_primary_10_1016_j_pnpbp_2023_110753
crossref_primary_10_1016_j_taap_2017_06_011
crossref_primary_10_1007_s00213_014_3713_0
crossref_primary_10_1016_j_neulet_2021_136121
crossref_primary_10_1016_j_scitotenv_2021_148629
crossref_primary_10_1016_j_pnpbp_2015_08_009
crossref_primary_10_3389_fneur_2018_00347
crossref_primary_10_1016_j_pbb_2019_172828
crossref_primary_10_1016_j_scitotenv_2022_156013
crossref_primary_10_1016_j_scitotenv_2023_164030
crossref_primary_10_1016_j_etap_2023_104242
crossref_primary_10_1021_acs_est_1c04724
crossref_primary_10_3390_toxics9100250
crossref_primary_10_1021_acschemneuro_6b00014
crossref_primary_10_1186_s12302_019_0270_5
crossref_primary_10_1080_01677063_2016_1177048
crossref_primary_10_1186_s12302_019_0188_y
crossref_primary_10_1016_j_scitotenv_2020_141783
crossref_primary_10_1016_j_ntt_2021_107034
crossref_primary_10_1371_journal_pone_0236606
crossref_primary_10_1021_acs_est_5b00558
crossref_primary_10_1016_j_cbpc_2021_109143
crossref_primary_10_1016_j_envint_2019_105293
crossref_primary_10_1016_j_envres_2020_109682
crossref_primary_10_3390_toxics12040282
crossref_primary_10_1021_acs_est_3c04070
crossref_primary_10_1002_etc_2906
crossref_primary_10_3390_ijms18040710
crossref_primary_10_3390_ijms231710114
crossref_primary_10_3390_ijms241311099
crossref_primary_10_1007_s12035_020_02160_5
crossref_primary_10_3389_fnins_2020_00458
crossref_primary_10_1007_s00213_016_4264_3
crossref_primary_10_1371_journal_pone_0090467
crossref_primary_10_1242_jeb_226092
crossref_primary_10_3389_fpsyt_2020_00703
crossref_primary_10_1016_j_aquatox_2014_11_001
crossref_primary_10_3390_ijms231810682
crossref_primary_10_1038_srep12546
crossref_primary_10_1016_j_ejphar_2015_03_027
crossref_primary_10_1098_rsbl_2017_0183
crossref_primary_10_1016_j_pnpbp_2016_01_002
crossref_primary_10_1038_laban_1345
crossref_primary_10_1111_jnc_13214
crossref_primary_10_1093_oons_kvac019
crossref_primary_10_1016_j_scitotenv_2023_168043
crossref_primary_10_1016_j_bbr_2019_112393
crossref_primary_10_1016_j_chemosphere_2017_05_054
crossref_primary_10_1080_02757540_2022_2153836
crossref_primary_10_1007_s11064_022_03618_9
crossref_primary_10_1063_1_5016381
crossref_primary_10_7554_eLife_07000
crossref_primary_10_1089_zeb_2013_0923
crossref_primary_10_1016_j_chemosphere_2021_132161
crossref_primary_10_1002_biot_202100561
crossref_primary_10_1016_j_ecoenv_2022_114007
crossref_primary_10_1039_D0EN00961J
crossref_primary_10_1016_j_envpol_2020_115895
crossref_primary_10_1016_j_ntt_2015_10_007
Cites_doi 10.1523/JNEUROSCI.5548-10.2011
10.1016/0014-2999(88)90309-3
10.1016/j.bbr.2009.10.008
10.1016/S0892-0362(03)00009-6
10.1007/BF02245065
10.1016/0014-4886(81)90092-3
10.1016/j.schres.2004.08.003
10.1002/ana.410320715
10.1007/BF00428819
10.1002/aja.1002030302
10.1037/a0017702
10.1242/jeb.003939
10.1002/jez.b.21127
10.1001/archneur.61.5.641
10.1007/BF03033375
10.1016/0042-6989(83)90104-9
10.1186/1471-2202-11-90
10.1016/j.ntt.2009.04.066
10.1023/A:1006988603199
10.1007/978-1-4419-0322-8_1
10.1016/S0301-0082(02)00075-8
10.1124/jpet.102.039867
10.1016/0091-3057(94)90346-8
10.1038/ncomms1171
10.1097/FBP.0b013e32833a5c68
10.1016/j.pnpbp.2011.10.002
10.1034/j.1601-183X.2003.00038.x
10.1089/zeb.2006.3.235
10.1016/S0006-8993(00)03174-7
10.1002/dvdy.20075
10.1007/BF02821713
10.1089/zeb.2010.0669
10.1152/jn.1969.32.3.424
10.1002/dneu.20911
10.1126/science.1183090
10.1016/0014-2999(83)90381-3
10.1152/physrev.1998.78.1.189
10.1038/nchembio.307
10.1016/j.visres.2008.07.019
10.1016/j.nbd.2011.05.016
10.1192/bjp.167.4.480
10.1016/j.expneurol.2004.05.044
10.1016/j.ntt.2006.01.013
10.1007/BF00444699
10.1016/j.neuroscience.2009.12.033
10.1016/j.cub.2012.08.016
10.1523/JNEUROSCI.5094-09.2010
10.1016/0014-2999(86)90588-1
10.1111/j.1601-183X.2006.00243.x
10.1016/j.tins.2007.03.002
10.1354/vp.42-6-753
10.1016/0893-133X(94)00129-N
10.1016/S0165-3806(02)00354-1
10.1523/JNEUROSCI.20-16-j0001.2000
10.1523/JNEUROSCI.21-12-04390.2001
10.1016/j.neuro.2008.09.011
10.1126/science.3975635
10.1523/JNEUROSCI.1279-07.2007
10.1007/s002130050396
10.1016/j.brainres.2010.06.020
10.1007/s00702-007-0009-0
10.1016/0892-0362(89)90018-4
10.1016/0014-2999(79)90215-2
10.1016/j.bbr.2011.05.034
10.1002/dvdy.21130
ContentType Journal Article
Copyright 2012
Published by Elsevier Inc.
Copyright_xml – notice: 2012
– notice: Published by Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
5PM
DOI 10.1016/j.pbb.2012.12.010
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Psychology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-5177
EndPage 813
ExternalDocumentID 10_1016_j_pbb_2012_12_010
23274813
S0091305712003346
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: T32 DA007244
– fundername: NIEHS NIH HHS
  grantid: T32 ES007126
– fundername: National Institute of Environmental Health Sciences : NIEHS
  grantid: T32 ES007126 || ES
GroupedDBID ---
--K
--M
-DZ
.GJ
.~1
0R~
123
1B1
1RT
1~.
1~5
29O
4.4
41~
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AADPK
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXLA
AAXUO
ABCQJ
ABFNM
ABFRF
ABGSF
ABIVO
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADIYS
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HMQ
HMT
HVGLF
HZ~
H~9
IHE
J1W
KOM
LX3
M2V
M34
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SNS
SPCBC
SPT
SSN
SSP
SSU
SSZ
T5K
TEORI
WUQ
XJT
XPP
YYP
ZGI
~G-
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
ADNMO
CITATION
5PM
ID FETCH-LOGICAL-c517t-f636626a5fb3ddfc5ad12dd0602861a98d7cbe711585498ba15e31c43a4ffb733
IEDL.DBID .~1
ISSN 0091-3057
IngestDate Tue Sep 17 21:26:53 EDT 2024
Fri Dec 06 01:42:33 EST 2024
Sat Sep 28 07:52:12 EDT 2024
Fri Feb 23 02:29:17 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Zebrafish
Dopamine
Receptor
Acute
Locomotor activity
Language English
License Published by Elsevier Inc.
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-f636626a5fb3ddfc5ad12dd0602861a98d7cbe711585498ba15e31c43a4ffb733
OpenAccessLink https://europepmc.org/articles/pmc3640837?pdf=render
PMID 23274813
PageCount 22
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3640837
crossref_primary_10_1016_j_pbb_2012_12_010
pubmed_primary_23274813
elsevier_sciencedirect_doi_10_1016_j_pbb_2012_12_010
PublicationCentury 2000
PublicationDate 2013-02-01
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 2013-02-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Pharmacology, biochemistry and behavior
PublicationTitleAlternate Pharmacol Biochem Behav
PublicationYear 2013
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References National Research Council (bb0260) 2011
Kolasiewicz, Maj, Ossowska (bb0205) 2008; 115
Van der Weide, Tendijck, Tepper, De Vries, Dubocovich, Horn (bb0375) 1988; 146
Van Hartesveldt, Meyer, Potter (bb0380) 1994; 48
Shireen, Haleem (bb0340) 2011; 24
King, Burke, Lucas (bb0195) 1995; 167
Voith, Herr (bb0395) 1975; 42
Zeiss (bb0415) 2005; 42
Panula, Sallinen, Sundvik, Kolehmainen, Torkko, Tiittula (bb0295) 2006; 3
Boehmler, Carr, Thisse, Thisse, Canfield, Levenson (bb0035) 2007; 6
Kokel, Bryan, Laggner, White, Cheung, Mateus (bb0200) 2010; 6
Fetcho (bb0110) 2007; 308
Archer, Palomo, McArthur, Fredriksson (bb0010) 2003; 5
Seibt, Piato, da Luz Oliveira, Capiotti, Vianna, Bonan (bb0335) 2011; 224
Sobrian, Jones, Varghese, Holson (bb0345) 2003; 25
Bowton, Saunders, Erreger, Sakrikar, Matthies, Sen (bb0040) 2010; 30
Melo, Santos, Medeiros, Mello, Ferrari, Brandao (bb0235) 2010; 1349
Li, Shah, Huang, Carr, Gao, Thisse (bb0210) 2007; 236
Bergman, Madras, Spealman (bb0025) 1991; 258
Farrell, Cario, Milanese, Vogt, Jeong, Burton (bb0100) 2011; 44
Souza, Romano-Silva, Tropepe (bb0355) 2011; 31
Hyttel (bb0165) 1983; 91
Norton, Bally-Cuif (bb0275) 2010; 11
Obadiah, Avidor-Reiss, Fishburn, Carmon, Bayewitch, Vogel (bb0285) 1999; 19
Morato, Lemos, Takahashi (bb0250) 1989; 11
Ames, Pollen (bb0005) 1969; 32
Savio, Vuaden, Piato, Bonan, Wyse (bb0320) 2011; 36
Missale, Nash, Robinson, Jaber, Caron (bb0245) 1998; 78
Schweitzer, Löhr, Filippi, Driever (bb0330) 2012; 72
Tropepe, Sive (bb0365) 2003; 2
Boehmler, Obrecht-Pflumio, Canfield, Thisse, Thisse, Levenson (bb0030) 2004; 230
Braun, Chase (bb0045) 1986; 131
Drapeau, Saint-Amant, Buss, Chong, McDearmid, Brustein (bb0085) 2002; 68
Han, Nakanishi, Tran, Whelan (bb0145) 2007; 27
Beninger, Mazurski, Hoffman (bb0020) 1991; 43
Murray, Waddington (bb0255) 1989; 98
Giacomini, Rose, Kobayashi, Guo (bb0120) 2006; 28
MacPhail, Brooks, Hunter, Padnos, Irons, Padilla (bb0225) 2009; 30
Dyer, Howell, MacPhail (bb0090) 1981; 71
Herve, Le Moine, Corvol, Belluscio, Ledent, Fienberg (bb0150) 2001; 21
Zhuang, Belluscio, Hen (bb0420) 2000; 20
Hooks, Jones, Holtzman, Juncos, Kalivas, Justice (bb0160) 1994; 116
Girault, Greengard (bb0125) 2004; 61
Lynch, King, Green, Byth, Wilson-Davis (bb0220) 1997; 133
Burgess, Granato (bb0050) 2007; 210
Grillner (bb0130) 1985; 228
Iversen, Iversen (bb0175) 2007; 30
Jensen, Daw (bb0180) 1983; 23
Oberlander, Euvrard, Dumont, Boissier (bb0290) 1979; 60
Rink, Wullimann (bb0315) 2002; 137
Ardayfio, Leung, Park, Hwang, Moran-Gates, Choi (bb0015) 2010; 166
Gerlai (bb0115) 2010; 207
Kimmel (bb0190) 1995; 203
Nguyen-Legros, Versaux-Botteri, Vernier (bb0270) 1999; 19
Hirsch (bb0155) 1992; 32
Irons, MacPhail, Hunter, Padilla (bb0170) 2010; 32
Rink, Wullimann (bb0310) 2001; 889
Vitalis, Cases, Parnavelas (bb0390) 2005; 191
Maximino, Herculano (bb0230) 2010; 7
Joselevitch, Kamermans (bb0185) 2009; 49
Millan, Maiofiss, Cussac, Audinot, Boutin, Newman-Tancredi (bb0240) 2002; 303
Tay, Ronneberger, Ryu, Nitschke, Driever (bb0360) 2011; 2
Choi, Morvan, Balsam, Horvitz (bb0065) 2009; 123
Schweitzer, Driever (bb0325) 2009; 651
Cortese, Caligiuri, Malla, Manchanda, Takhar, Haricharan (bb0075) 2005; 75
Bymaster, Calligaro, Falcone, Marsh, Moore, Tye (bb0055) 1996; 14
Li, Collins, Paul, Grundt, Newman, Xu (bb0215) 2010; 21
Rihel, Prober, Arvanites, Lam, Zimmerman, Jang (bb0305) 2010; 327
Fernandes, Fero, Arrenberg, Bergeron, Driever, Burgess (bb0105) 2012; 22
Emran, Rihel, Dowling (bb0095) 2008; 20
Ungerstedt (bb0370) 1976; 2
20075256 - Science. 2010 Jan 15;327(5963):348-51
21567980 - Dev Neurobiol. 2012 Mar;72(3):256-68
18248264 - Zebrafish. 2006;3(2):235-47
1281499 - J Neurosci. 1992 Dec;12(12):4911-22
18722397 - Vision Res. 2009 May;49(9):943-59
21669233 - Behav Brain Res. 2011 Oct 10;224(1):135-9
4308417 - J Neurophysiol. 1969 May;32(3):424-42
16764679 - Genes Brain Behav. 2007 Mar;6(2):155-66
19465114 - Neurotoxicol Teratol. 2010 Jan-Feb;32(1):84-90
1402901 - J Neurochem. 1992 Oct;59(4):1499-505
8950093 - Eur J Neurosci. 1996 Nov;8(11):2286-97
2836210 - Eur J Pharmacol. 1988 Feb 9;146(2-3):319-26
7938135 - Pharmacol Biochem Behav. 1994 Jul;48(3):781-6
16301571 - Vet Pathol. 2005 Nov;42(6):753-73
8509505 - J Comp Neurol. 1993 May 22;331(4):469-81
12388666 - J Pharmacol Exp Ther. 2002 Nov;303(2):791-804
3975635 - Science. 1985 Apr 12;228(4696):143-9
14606692 - Genes Brain Behav. 2003 Oct;2(5):268-81
772721 - Pharmacol Ther B. 1976;2(1):37-40
20081854 - Nat Chem Biol. 2010 Mar;6(3):231-237
1687945 - Pol J Pharmacol Pharm. 1991 Nov-Dec;43(6):507-28
2150768 - Brain Res. 1990 Nov 12;533(1):20-3
21669287 - Neurobiol Dis. 2011 Oct;44(1):9-18
15148138 - Arch Neurol. 2004 May;61(5):641-4
6138794 - Psychopharmacology (Berl). 1983;81(2):126-34
1890625 - J Pharmacol Exp Ther. 1991 Sep;258(3):910-7
11166725 - Brain Res. 2001 Jan 19;889(1-2):316-30
1171496 - Psychopharmacologia. 1975 Apr 30;42(1):11-20
12832225 - Neurotox Res. 2003;5(1-2):95-110
3293703 - Brain Res. 1988 May 24;449(1-2):332-6
2569218 - Psychopharmacology (Berl). 1989;98(2):245-50
12757828 - Neurotoxicol Teratol. 2003 May-Jun;25(3):311-28
18188494 - J Neural Transm (Vienna). 2008 May;115(5):677-81
20558148 - Brain Res. 2010 Aug 19;1349:41-7
11404425 - J Neurosci. 2001 Jun 15;21(12):4390-9
8589427 - Dev Dyn. 1995 Jul;203(3):253-310
17024661 - J Exp Zool B Mol Dev Evol. 2007 Sep 15;308(5):550-62
20001111 - Behav Neurosci. 2009 Dec;123(6):1279-87
20427663 - J Neurosci. 2010 Apr 28;30(17):6048-57
19078942 - J Vis Exp. 2008;(20). pii: 923. doi: 10.3791/923
20678210 - BMC Neurosci. 2010;11:90
10384262 - Cell Mol Neurobiol. 1999 Oct;19(5):653-64
15629757 - Exp Neurol. 2005 Feb;191 Suppl 1:S104-12
1975644 - Nature. 1990 Sep 13;347(6289):146-51
21190911 - Pak J Pharm Sci. 2011 Jan;24(1):7-12
6256200 - Exp Neurol. 1981 Feb;71(2):326-40
21158565 - Zebrafish. 2010 Dec;7(4):359-78
1510386 - Ann Neurol. 1992;32 Suppl:S88-93
19836422 - Behav Brain Res. 2010 Mar 5;207(2):223-31
10924528 - J Neurosci. 2000 Aug 15;20(16):RC91
19731546 - Adv Exp Med Biol. 2009;651:1-14
22019856 - Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):258-63
1334557 - Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12093-7
23000151 - Curr Biol. 2012 Nov 6;22(21):2042-7
20026251 - Neuroscience. 2010 Mar 17;166(2):391-6
575095 - Eur J Pharmacol. 1979 Dec 7;60(2-3):163-70
12128258 - Brain Res Dev Brain Res. 2002 Jul 30;137(1):89-100
7862951 - Psychopharmacology (Berl). 1994 Oct;116(2):217-25
18952124 - Neurotoxicology. 2009 Jan;30(1):52-8
8822531 - Neuropsychopharmacology. 1996 Feb;14(2):87-96
9194321 - Vis Neurosci. 1997 May-Jun;14(3):545-51
2593980 - Neurotoxicol Teratol. 1989 Sep-Oct;11(5):421-5
1835903 - Cell Mol Neurobiol. 1991 Oct;11(5):437-53
21471388 - J Neurosci. 2011 Apr 6;31(14):5512-25
16527449 - Neurotoxicol Teratol. 2006 Mar-Apr;28(2):245-50
4070332 - Pharmacol Biochem Behav. 1985 Oct;23(4):555-7
15820325 - Schizophr Res. 2005 Jun 1;75(1):65-75
15188433 - Dev Dyn. 2004 Jul;230(3):481-93
17601957 - J Exp Biol. 2007 Jul;210(Pt 14):2526-39
17393486 - Dev Dyn. 2007 May;236(5):1339-46
20463460 - Behav Pharmacol. 2010 May;21(3):171-81
8348331 - Brain Res. 1993 Jun 18;614(1-2):57-64
3493161 - Eur J Pharmacol. 1986 Nov 19;131(2-3):301-6
6659376 - Vision Res. 1983;23(11):1293-8
8829716 - Br J Psychiatry. 1995 Oct;167(4):480-2
21266970 - Nat Commun. 2011 Jan 25;2:171
6225651 - Eur J Pharmacol. 1983 Jul 15;91(1):153-4
12450489 - Prog Neurobiol. 2002 Oct;68(2):85-111
9361328 - Psychopharmacology (Berl). 1997 Oct;133(3):233-9
9457173 - Physiol Rev. 1998 Jan;78(1):189-225
10495103 - Mol Neurobiol. 1999 Jun;19(3):181-204
18045913 - J Neurosci. 2007 Nov 28;27(48):13192-204
17368565 - Trends Neurosci. 2007 May;30(5):188-93
Shireen (10.1016/j.pbb.2012.12.010_bb0340) 2011; 24
Boehmler (10.1016/j.pbb.2012.12.010_bb0030) 2004; 230
Schweitzer (10.1016/j.pbb.2012.12.010_bb0330) 2012; 72
Ungerstedt (10.1016/j.pbb.2012.12.010_bb0370) 1976; 2
Herve (10.1016/j.pbb.2012.12.010_bb0150) 2001; 21
Schweitzer (10.1016/j.pbb.2012.12.010_bb0325) 2009; 651
Tropepe (10.1016/j.pbb.2012.12.010_bb0365) 2003; 2
Iversen (10.1016/j.pbb.2012.12.010_bb0175) 2007; 30
Boehmler (10.1016/j.pbb.2012.12.010_bb0035) 2007; 6
Li (10.1016/j.pbb.2012.12.010_bb0215) 2010; 21
Fetcho (10.1016/j.pbb.2012.12.010_bb0110) 2007; 308
Lynch (10.1016/j.pbb.2012.12.010_bb0220) 1997; 133
Hyttel (10.1016/j.pbb.2012.12.010_bb0165) 1983; 91
Archer (10.1016/j.pbb.2012.12.010_bb0010) 2003; 5
King (10.1016/j.pbb.2012.12.010_bb0195) 1995; 167
Missale (10.1016/j.pbb.2012.12.010_bb0245) 1998; 78
Drapeau (10.1016/j.pbb.2012.12.010_bb0085) 2002; 68
Millan (10.1016/j.pbb.2012.12.010_bb0240) 2002; 303
Nguyen-Legros (10.1016/j.pbb.2012.12.010_bb0270) 1999; 19
Fernandes (10.1016/j.pbb.2012.12.010_bb0105) 2012; 22
Seibt (10.1016/j.pbb.2012.12.010_bb0335) 2011; 224
Beninger (10.1016/j.pbb.2012.12.010_bb0020) 1991; 43
Dyer (10.1016/j.pbb.2012.12.010_bb0090) 1981; 71
Bymaster (10.1016/j.pbb.2012.12.010_bb0055) 1996; 14
Grillner (10.1016/j.pbb.2012.12.010_bb0130) 1985; 228
Kokel (10.1016/j.pbb.2012.12.010_bb0200) 2010; 6
Braun (10.1016/j.pbb.2012.12.010_bb0045) 1986; 131
Zeiss (10.1016/j.pbb.2012.12.010_bb0415) 2005; 42
Irons (10.1016/j.pbb.2012.12.010_bb0170) 2010; 32
Rink (10.1016/j.pbb.2012.12.010_bb0310) 2001; 889
Jensen (10.1016/j.pbb.2012.12.010_bb0180) 1983; 23
National Research Council (10.1016/j.pbb.2012.12.010_bb0260) 2011
Melo (10.1016/j.pbb.2012.12.010_bb0235) 2010; 1349
Gerlai (10.1016/j.pbb.2012.12.010_bb0115) 2010; 207
Sobrian (10.1016/j.pbb.2012.12.010_bb0345) 2003; 25
Savio (10.1016/j.pbb.2012.12.010_bb0320) 2011; 36
Hooks (10.1016/j.pbb.2012.12.010_bb0160) 1994; 116
Kolasiewicz (10.1016/j.pbb.2012.12.010_bb0205) 2008; 115
Van der Weide (10.1016/j.pbb.2012.12.010_bb0375) 1988; 146
Li (10.1016/j.pbb.2012.12.010_bb0210) 2007; 236
Hirsch (10.1016/j.pbb.2012.12.010_bb0155) 1992; 32
Bowton (10.1016/j.pbb.2012.12.010_bb0040) 2010; 30
Bergman (10.1016/j.pbb.2012.12.010_bb0025) 1991; 258
Oberlander (10.1016/j.pbb.2012.12.010_bb0290) 1979; 60
Voith (10.1016/j.pbb.2012.12.010_bb0395) 1975; 42
Han (10.1016/j.pbb.2012.12.010_bb0145) 2007; 27
Giacomini (10.1016/j.pbb.2012.12.010_bb0120) 2006; 28
Souza (10.1016/j.pbb.2012.12.010_bb0355) 2011; 31
Cortese (10.1016/j.pbb.2012.12.010_bb0075) 2005; 75
Ardayfio (10.1016/j.pbb.2012.12.010_bb0015) 2010; 166
Obadiah (10.1016/j.pbb.2012.12.010_bb0285) 1999; 19
Kimmel (10.1016/j.pbb.2012.12.010_bb0190) 1995; 203
Panula (10.1016/j.pbb.2012.12.010_bb0295) 2006; 3
MacPhail (10.1016/j.pbb.2012.12.010_bb0225) 2009; 30
Rihel (10.1016/j.pbb.2012.12.010_bb0305) 2010; 327
Vitalis (10.1016/j.pbb.2012.12.010_bb0390) 2005; 191
Joselevitch (10.1016/j.pbb.2012.12.010_bb0185) 2009; 49
Burgess (10.1016/j.pbb.2012.12.010_bb0050) 2007; 210
Farrell (10.1016/j.pbb.2012.12.010_bb0100) 2011; 44
Girault (10.1016/j.pbb.2012.12.010_bb0125) 2004; 61
Maximino (10.1016/j.pbb.2012.12.010_bb0230) 2010; 7
Tay (10.1016/j.pbb.2012.12.010_bb0360) 2011; 2
Ames (10.1016/j.pbb.2012.12.010_bb0005) 1969; 32
Emran (10.1016/j.pbb.2012.12.010_bb0095) 2008; 20
Murray (10.1016/j.pbb.2012.12.010_bb0255) 1989; 98
Zhuang (10.1016/j.pbb.2012.12.010_bb0420) 2000; 20
Van Hartesveldt (10.1016/j.pbb.2012.12.010_bb0380) 1994; 48
Choi (10.1016/j.pbb.2012.12.010_bb0065) 2009; 123
Rink (10.1016/j.pbb.2012.12.010_bb0315) 2002; 137
Morato (10.1016/j.pbb.2012.12.010_bb0250) 1989; 11
Norton (10.1016/j.pbb.2012.12.010_bb0275) 2010; 11
References_xml – volume: 7
  start-page: 359
  year: 2010
  end-page: 378
  ident: bb0230
  article-title: A review of monoaminergic neuropsychopharmacology in zebrafish
  publication-title: Zebrafish
  contributor:
    fullname: Herculano
– volume: 115
  start-page: 677
  year: 2008
  end-page: 681
  ident: bb0205
  article-title: The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats
  publication-title: J Neural Transm
  contributor:
    fullname: Ossowska
– volume: 30
  start-page: 6048
  year: 2010
  end-page: 6057
  ident: bb0040
  article-title: Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder
  publication-title: J Neurosci
  contributor:
    fullname: Sen
– volume: 32
  start-page: 84
  year: 2010
  end-page: 90
  ident: bb0170
  article-title: Acute neuroactive drug exposures alter locomotor activity in larval zebrafish
  publication-title: Neurotoxicol Teratol
  contributor:
    fullname: Padilla
– volume: 27
  start-page: 13192
  year: 2007
  end-page: 13204
  ident: bb0145
  article-title: Dopaminergic modulation of spinal neuronal excitability
  publication-title: J Neurosci
  contributor:
    fullname: Whelan
– volume: 228
  start-page: 143
  year: 1985
  end-page: 149
  ident: bb0130
  article-title: Neurobiological bases of rhythmic motor acts in vertebrates
  publication-title: Science
  contributor:
    fullname: Grillner
– volume: 42
  start-page: 753
  year: 2005
  end-page: 773
  ident: bb0415
  article-title: Neuroanatomical phenotyping in the mouse: the dopaminergic system
  publication-title: Vet Pathol
  contributor:
    fullname: Zeiss
– volume: 207
  start-page: 223
  year: 2010
  end-page: 231
  ident: bb0115
  article-title: Zebrafish antipredatory responses: a future for translational research?
  publication-title: Behav Brain Res
  contributor:
    fullname: Gerlai
– volume: 31
  start-page: 5512
  year: 2011
  end-page: 5525
  ident: bb0355
  article-title: Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae
  publication-title: J Neurosci
  contributor:
    fullname: Tropepe
– volume: 71
  start-page: 326
  year: 1981
  end-page: 340
  ident: bb0090
  article-title: Dopamine depletion slows retinal transmission
  publication-title: Exp Neurol
  contributor:
    fullname: MacPhail
– volume: 889
  start-page: 316
  year: 2001
  end-page: 330
  ident: bb0310
  article-title: The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum)
  publication-title: Brain Res
  contributor:
    fullname: Wullimann
– volume: 203
  start-page: 253
  year: 1995
  end-page: 310
  ident: bb0190
  article-title: Stages of embryonic development of the zebrafish
  publication-title: Dev Dyn
  contributor:
    fullname: Kimmel
– volume: 11
  start-page: 421
  year: 1989
  end-page: 425
  ident: bb0250
  article-title: Acute exposure to maneb alters some behavioral functions in the mouse
  publication-title: Neurotoxicol Teratol
  contributor:
    fullname: Takahashi
– volume: 2
  start-page: 37
  year: 1976
  end-page: 40
  ident: bb0370
  article-title: 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome
  publication-title: Pharmacol Ther B
  contributor:
    fullname: Ungerstedt
– volume: 19
  start-page: 653
  year: 1999
  end-page: 664
  ident: bb0285
  article-title: Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs
  publication-title: Cell Mol Neurobiol
  contributor:
    fullname: Vogel
– volume: 28
  start-page: 245
  year: 2006
  end-page: 250
  ident: bb0120
  article-title: Antipsychotics produce locomotor impairment in larval zebrafish
  publication-title: Neurotoxicol Teratol
  contributor:
    fullname: Guo
– volume: 30
  start-page: 52
  year: 2009
  end-page: 58
  ident: bb0225
  article-title: Locomotion in larval zebrafish: influence of time of day, lighting and ethanol
  publication-title: Neurotoxicology
  contributor:
    fullname: Padilla
– volume: 258
  start-page: 910
  year: 1991
  end-page: 917
  ident: bb0025
  article-title: Behavioral effects of D1 and D2 dopaminereceptor antagonists in squirrel monkeys
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Spealman
– volume: 327
  start-page: 348
  year: 2010
  end-page: 351
  ident: bb0305
  article-title: Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation
  publication-title: Science
  contributor:
    fullname: Jang
– volume: 651
  start-page: 1
  year: 2009
  end-page: 14
  ident: bb0325
  article-title: Development of the dopamine systems in zebrafish
  publication-title: Adv Exp Med Biol
  contributor:
    fullname: Driever
– volume: 32
  start-page: 424
  year: 1969
  end-page: 442
  ident: bb0005
  article-title: Neurotransmission in central nervous tissue: a study of isolated rabbit retina
  publication-title: J Neurophysiol
  contributor:
    fullname: Pollen
– volume: 167
  start-page: 480
  year: 1995
  end-page: 482
  ident: bb0195
  article-title: Antipsychotic drug-induced dysphoria
  publication-title: Br J Psychiatry
  contributor:
    fullname: Lucas
– volume: 21
  start-page: 4390
  year: 2001
  end-page: 4399
  ident: bb0150
  article-title: Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum
  publication-title: J Neurosci
  contributor:
    fullname: Fienberg
– volume: 91
  start-page: 153
  year: 1983
  end-page: 154
  ident: bb0165
  article-title: SCH 23390 - the first selective dopamine D-1 antagonist
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Hyttel
– volume: 230
  start-page: 481
  year: 2004
  end-page: 493
  ident: bb0030
  article-title: Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish
  publication-title: Dev Dyn
  contributor:
    fullname: Levenson
– volume: 133
  start-page: 233
  year: 1997
  end-page: 239
  ident: bb0220
  article-title: The effects of haloperidol on visual search, eye movements and psychomotor performance
  publication-title: Psychopharmacology (Berl)
  contributor:
    fullname: Wilson-Davis
– volume: 30
  start-page: 188
  year: 2007
  end-page: 193
  ident: bb0175
  article-title: Dopamine: 50
  publication-title: Trends Neurosci
  contributor:
    fullname: Iversen
– volume: 78
  start-page: 189
  year: 1998
  end-page: 225
  ident: bb0245
  article-title: Dopamine receptors: from structure to function
  publication-title: Physiol Rev
  contributor:
    fullname: Caron
– volume: 166
  start-page: 391
  year: 2010
  end-page: 396
  ident: bb0015
  article-title: Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs
  publication-title: Neuroscience
  contributor:
    fullname: Choi
– volume: 48
  start-page: 781
  year: 1994
  end-page: 786
  ident: bb0380
  article-title: Ontogeny of biphasic effects of quinpirole
  publication-title: Pharmacol Biochem Behav
  contributor:
    fullname: Potter
– volume: 49
  start-page: 943
  year: 2009
  end-page: 959
  ident: bb0185
  article-title: Retinal parallel pathways: seeing with our inner fish
  publication-title: Vision Res
  contributor:
    fullname: Kamermans
– volume: 210
  start-page: 2526
  year: 2007
  end-page: 2539
  ident: bb0050
  article-title: Modulation of locomotor activity in larval zebrafish during light adaptation
  publication-title: J Exp Biol
  contributor:
    fullname: Granato
– volume: 191
  start-page: S104
  year: 2005
  end-page: S112
  ident: bb0390
  article-title: Development of the dopaminergic neurons in the rodent brainstem
  publication-title: Exp Neurol
  contributor:
    fullname: Parnavelas
– volume: 61
  start-page: 641
  year: 2004
  end-page: 644
  ident: bb0125
  article-title: The neurobiology of dopamine signaling
  publication-title: Arch Neurol
  contributor:
    fullname: Greengard
– volume: 43
  start-page: 507
  year: 1991
  end-page: 528
  ident: bb0020
  article-title: Receptor subtype-specific dopaminergic agents and unconditioned behavior
  publication-title: Pol J Pharmacol Pharm
  contributor:
    fullname: Hoffman
– volume: 303
  start-page: 791
  year: 2002
  end-page: 804
  ident: bb0240
  article-title: Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Newman-Tancredi
– volume: 146
  start-page: 319
  year: 1988
  end-page: 326
  ident: bb0375
  article-title: The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Horn
– volume: 116
  start-page: 217
  year: 1994
  end-page: 225
  ident: bb0160
  article-title: Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole
  publication-title: Psychopharmacology (Berl)
  contributor:
    fullname: Justice
– volume: 3
  start-page: 235
  year: 2006
  end-page: 247
  ident: bb0295
  article-title: Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases
  publication-title: Zebrafish
  contributor:
    fullname: Tiittula
– volume: 36
  start-page: 258
  year: 2011
  end-page: 263
  ident: bb0320
  article-title: Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  contributor:
    fullname: Wyse
– volume: 75
  start-page: 65
  year: 2005
  end-page: 75
  ident: bb0075
  article-title: Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients
  publication-title: Schizophr Res
  contributor:
    fullname: Haricharan
– volume: 1349
  start-page: 41
  year: 2010
  end-page: 47
  ident: bb0235
  article-title: Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy
  publication-title: Brain Res
  contributor:
    fullname: Brandao
– volume: 19
  start-page: 181
  year: 1999
  end-page: 204
  ident: bb0270
  article-title: Dopamine receptor localization in the mammalian retina
  publication-title: Mol Neurobiol
  contributor:
    fullname: Vernier
– volume: 137
  start-page: 89
  year: 2002
  end-page: 100
  ident: bb0315
  article-title: Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study
  publication-title: Brain Res Dev Brain Res
  contributor:
    fullname: Wullimann
– volume: 44
  start-page: 9
  year: 2011
  end-page: 18
  ident: bb0100
  article-title: Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models
  publication-title: Neurobiol Dis
  contributor:
    fullname: Burton
– year: 2011
  ident: bb0260
  article-title: Guide for the Care and Use of Laboratory Animals
  contributor:
    fullname: National Research Council
– volume: 6
  start-page: 231
  year: 2010
  end-page: 237
  ident: bb0200
  article-title: Rapid behavior-based identification of neuroactive small molecules in the zebrafish
  publication-title: Nat Chem Biol
  contributor:
    fullname: Mateus
– volume: 20
  start-page: RC91
  year: 2000
  ident: bb0420
  article-title: G(olf)alpha mediates dopamine D1 receptor signaling
  publication-title: J Neurosci
  contributor:
    fullname: Hen
– volume: 5
  start-page: 95
  year: 2003
  end-page: 110
  ident: bb0010
  article-title: Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment
  publication-title: Neurotox Res
  contributor:
    fullname: Fredriksson
– volume: 60
  start-page: 163
  year: 1979
  end-page: 170
  ident: bb0290
  article-title: Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Boissier
– volume: 32
  start-page: S88
  year: 1992
  end-page: S93
  ident: bb0155
  article-title: Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
  publication-title: Ann Neurol
  contributor:
    fullname: Hirsch
– volume: 123
  start-page: 1279
  year: 2009
  end-page: 1287
  ident: bb0065
  article-title: Dopamine D1 and D2 antagonist effects on response likelihood and duration
  publication-title: Behav Neurosci
  contributor:
    fullname: Horvitz
– volume: 42
  start-page: 11
  year: 1975
  end-page: 20
  ident: bb0395
  article-title: The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug
  publication-title: Psychopharmacologia
  contributor:
    fullname: Herr
– volume: 2
  start-page: 268
  year: 2003
  end-page: 281
  ident: bb0365
  article-title: Can zebrafish be used as a model to study the neurodevelopmental causes of autism?
  publication-title: Genes Brain Behav
  contributor:
    fullname: Sive
– volume: 11
  start-page: 90
  year: 2010
  ident: bb0275
  article-title: Adult zebrafish as a model organism for behavioural genetics
  publication-title: BMC Neurosci
  contributor:
    fullname: Bally-Cuif
– volume: 224
  start-page: 135
  year: 2011
  end-page: 139
  ident: bb0335
  article-title: Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (
  publication-title: Behav Brain Res
  contributor:
    fullname: Bonan
– volume: 22
  start-page: 2042
  year: 2012
  end-page: 2047
  ident: bb0105
  article-title: Deep brain photoreceptors control light-seeking behavior in zebrafish larvae
  publication-title: Curr Biol
  contributor:
    fullname: Burgess
– volume: 2
  start-page: 171
  year: 2011
  ident: bb0360
  article-title: Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems
  publication-title: Nat Commun
  contributor:
    fullname: Driever
– volume: 25
  start-page: 311
  year: 2003
  end-page: 328
  ident: bb0345
  article-title: Behavioral response profiles following drug challenge with dopamine receptor subtype agonists and antagonists in developing rat
  publication-title: Neurotoxicol Teratol
  contributor:
    fullname: Holson
– volume: 6
  start-page: 155
  year: 2007
  end-page: 166
  ident: bb0035
  article-title: D4 Dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour
  publication-title: Genes Brain Behav
  contributor:
    fullname: Levenson
– volume: 68
  start-page: 85
  year: 2002
  end-page: 111
  ident: bb0085
  article-title: Development of the locomotor network in zebrafish
  publication-title: Prog Neurobiol
  contributor:
    fullname: Brustein
– volume: 14
  start-page: 87
  year: 1996
  end-page: 96
  ident: bb0055
  article-title: Radioreceptor binding profile of the atypical antipsychotic olanzapine
  publication-title: Neuropsychopharmacology
  contributor:
    fullname: Tye
– volume: 20
  start-page: 923
  year: 2008
  ident: bb0095
  article-title: Behavioral assay to measure responsiveness of zebrafish to changes in light increments and decrements
  publication-title: J Vis Exp
  contributor:
    fullname: Dowling
– volume: 24
  start-page: 7
  year: 2011
  end-page: 12
  ident: bb0340
  article-title: Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats
  publication-title: Pak J Pharm Sci
  contributor:
    fullname: Haleem
– volume: 236
  start-page: 1339
  year: 2007
  end-page: 1346
  ident: bb0210
  article-title: Cloning and spatial and temporal expression of the zebrafish dopamine D1 receptor
  publication-title: Dev Dyn
  contributor:
    fullname: Thisse
– volume: 21
  start-page: 171
  year: 2010
  end-page: 181
  ident: bb0215
  article-title: Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rice
  publication-title: Behav Pharmacol
  contributor:
    fullname: Xu
– volume: 72
  start-page: 256
  year: 2012
  end-page: 268
  ident: bb0330
  article-title: Dopaminergic and noradrenergic circuit development in zebrafish
  publication-title: Dev Neurobiol
  contributor:
    fullname: Driever
– volume: 23
  start-page: 1293
  year: 1983
  end-page: 1298
  ident: bb0180
  article-title: Towards an understanding of the role of dopamine in the mammalian retina
  publication-title: Vision Res
  contributor:
    fullname: Daw
– volume: 131
  start-page: 301
  year: 1986
  end-page: 306
  ident: bb0045
  article-title: Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Chase
– volume: 308
  start-page: 550
  year: 2007
  end-page: 562
  ident: bb0110
  article-title: The utility of zebrafish for studies of the comparative biology of motor systems
  publication-title: J Exp Zool B Mol Dev Evol
  contributor:
    fullname: Fetcho
– volume: 98
  start-page: 245
  year: 1989
  end-page: 250
  ident: bb0255
  article-title: Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502
  publication-title: Psychopharmacology (Berl)
  contributor:
    fullname: Waddington
– volume: 31
  start-page: 5512
  year: 2011
  ident: 10.1016/j.pbb.2012.12.010_bb0355
  article-title: Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5548-10.2011
  contributor:
    fullname: Souza
– volume: 146
  start-page: 319
  year: 1988
  ident: 10.1016/j.pbb.2012.12.010_bb0375
  article-title: The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(88)90309-3
  contributor:
    fullname: Van der Weide
– volume: 207
  start-page: 223
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0115
  article-title: Zebrafish antipredatory responses: a future for translational research?
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2009.10.008
  contributor:
    fullname: Gerlai
– volume: 25
  start-page: 311
  year: 2003
  ident: 10.1016/j.pbb.2012.12.010_bb0345
  article-title: Behavioral response profiles following drug challenge with dopamine receptor subtype agonists and antagonists in developing rat
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/S0892-0362(03)00009-6
  contributor:
    fullname: Sobrian
– volume: 24
  start-page: 7
  year: 2011
  ident: 10.1016/j.pbb.2012.12.010_bb0340
  article-title: Reversal of haloperidol-induced motor deficits by mianserin and mesulergine in rats
  publication-title: Pak J Pharm Sci
  contributor:
    fullname: Shireen
– volume: 116
  start-page: 217
  year: 1994
  ident: 10.1016/j.pbb.2012.12.010_bb0160
  article-title: Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/BF02245065
  contributor:
    fullname: Hooks
– volume: 71
  start-page: 326
  year: 1981
  ident: 10.1016/j.pbb.2012.12.010_bb0090
  article-title: Dopamine depletion slows retinal transmission
  publication-title: Exp Neurol
  doi: 10.1016/0014-4886(81)90092-3
  contributor:
    fullname: Dyer
– volume: 75
  start-page: 65
  year: 2005
  ident: 10.1016/j.pbb.2012.12.010_bb0075
  article-title: Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2004.08.003
  contributor:
    fullname: Cortese
– volume: 32
  start-page: S88
  year: 1992
  ident: 10.1016/j.pbb.2012.12.010_bb0155
  article-title: Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
  publication-title: Ann Neurol
  doi: 10.1002/ana.410320715
  contributor:
    fullname: Hirsch
– volume: 42
  start-page: 11
  year: 1975
  ident: 10.1016/j.pbb.2012.12.010_bb0395
  article-title: The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug
  publication-title: Psychopharmacologia
  doi: 10.1007/BF00428819
  contributor:
    fullname: Voith
– volume: 203
  start-page: 253
  year: 1995
  ident: 10.1016/j.pbb.2012.12.010_bb0190
  article-title: Stages of embryonic development of the zebrafish
  publication-title: Dev Dyn
  doi: 10.1002/aja.1002030302
  contributor:
    fullname: Kimmel
– volume: 123
  start-page: 1279
  year: 2009
  ident: 10.1016/j.pbb.2012.12.010_bb0065
  article-title: Dopamine D1 and D2 antagonist effects on response likelihood and duration
  publication-title: Behav Neurosci
  doi: 10.1037/a0017702
  contributor:
    fullname: Choi
– volume: 210
  start-page: 2526
  year: 2007
  ident: 10.1016/j.pbb.2012.12.010_bb0050
  article-title: Modulation of locomotor activity in larval zebrafish during light adaptation
  publication-title: J Exp Biol
  doi: 10.1242/jeb.003939
  contributor:
    fullname: Burgess
– volume: 308
  start-page: 550
  year: 2007
  ident: 10.1016/j.pbb.2012.12.010_bb0110
  article-title: The utility of zebrafish for studies of the comparative biology of motor systems
  publication-title: J Exp Zool B Mol Dev Evol
  doi: 10.1002/jez.b.21127
  contributor:
    fullname: Fetcho
– volume: 61
  start-page: 641
  year: 2004
  ident: 10.1016/j.pbb.2012.12.010_bb0125
  article-title: The neurobiology of dopamine signaling
  publication-title: Arch Neurol
  doi: 10.1001/archneur.61.5.641
  contributor:
    fullname: Girault
– volume: 5
  start-page: 95
  year: 2003
  ident: 10.1016/j.pbb.2012.12.010_bb0010
  article-title: Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment
  publication-title: Neurotox Res
  doi: 10.1007/BF03033375
  contributor:
    fullname: Archer
– volume: 23
  start-page: 1293
  year: 1983
  ident: 10.1016/j.pbb.2012.12.010_bb0180
  article-title: Towards an understanding of the role of dopamine in the mammalian retina
  publication-title: Vision Res
  doi: 10.1016/0042-6989(83)90104-9
  contributor:
    fullname: Jensen
– volume: 11
  start-page: 90
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0275
  article-title: Adult zebrafish as a model organism for behavioural genetics
  publication-title: BMC Neurosci
  doi: 10.1186/1471-2202-11-90
  contributor:
    fullname: Norton
– volume: 32
  start-page: 84
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0170
  article-title: Acute neuroactive drug exposures alter locomotor activity in larval zebrafish
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/j.ntt.2009.04.066
  contributor:
    fullname: Irons
– volume: 19
  start-page: 653
  year: 1999
  ident: 10.1016/j.pbb.2012.12.010_bb0285
  article-title: Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs
  publication-title: Cell Mol Neurobiol
  doi: 10.1023/A:1006988603199
  contributor:
    fullname: Obadiah
– volume: 651
  start-page: 1
  year: 2009
  ident: 10.1016/j.pbb.2012.12.010_bb0325
  article-title: Development of the dopamine systems in zebrafish
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4419-0322-8_1
  contributor:
    fullname: Schweitzer
– volume: 68
  start-page: 85
  year: 2002
  ident: 10.1016/j.pbb.2012.12.010_bb0085
  article-title: Development of the locomotor network in zebrafish
  publication-title: Prog Neurobiol
  doi: 10.1016/S0301-0082(02)00075-8
  contributor:
    fullname: Drapeau
– volume: 303
  start-page: 791
  year: 2002
  ident: 10.1016/j.pbb.2012.12.010_bb0240
  article-title: Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.102.039867
  contributor:
    fullname: Millan
– volume: 48
  start-page: 781
  year: 1994
  ident: 10.1016/j.pbb.2012.12.010_bb0380
  article-title: Ontogeny of biphasic effects of quinpirole
  publication-title: Pharmacol Biochem Behav
  doi: 10.1016/0091-3057(94)90346-8
  contributor:
    fullname: Van Hartesveldt
– volume: 2
  start-page: 171
  year: 2011
  ident: 10.1016/j.pbb.2012.12.010_bb0360
  article-title: Comprehensive catecholaminergic projectome analysis reveals single-neuron integration of zebrafish ascending and descending dopaminergic systems
  publication-title: Nat Commun
  doi: 10.1038/ncomms1171
  contributor:
    fullname: Tay
– volume: 21
  start-page: 171
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0215
  article-title: Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rice
  publication-title: Behav Pharmacol
  doi: 10.1097/FBP.0b013e32833a5c68
  contributor:
    fullname: Li
– volume: 36
  start-page: 258
  year: 2011
  ident: 10.1016/j.pbb.2012.12.010_bb0320
  article-title: Behavioral changes induced by long-term proline exposure are reversed by antipsychotics in zebrafish
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2011.10.002
  contributor:
    fullname: Savio
– volume: 2
  start-page: 268
  year: 2003
  ident: 10.1016/j.pbb.2012.12.010_bb0365
  article-title: Can zebrafish be used as a model to study the neurodevelopmental causes of autism?
  publication-title: Genes Brain Behav
  doi: 10.1034/j.1601-183X.2003.00038.x
  contributor:
    fullname: Tropepe
– volume: 3
  start-page: 235
  year: 2006
  ident: 10.1016/j.pbb.2012.12.010_bb0295
  article-title: Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases
  publication-title: Zebrafish
  doi: 10.1089/zeb.2006.3.235
  contributor:
    fullname: Panula
– volume: 889
  start-page: 316
  year: 2001
  ident: 10.1016/j.pbb.2012.12.010_bb0310
  article-title: The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum)
  publication-title: Brain Res
  doi: 10.1016/S0006-8993(00)03174-7
  contributor:
    fullname: Rink
– volume: 230
  start-page: 481
  year: 2004
  ident: 10.1016/j.pbb.2012.12.010_bb0030
  article-title: Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish
  publication-title: Dev Dyn
  doi: 10.1002/dvdy.20075
  contributor:
    fullname: Boehmler
– volume: 19
  start-page: 181
  year: 1999
  ident: 10.1016/j.pbb.2012.12.010_bb0270
  article-title: Dopamine receptor localization in the mammalian retina
  publication-title: Mol Neurobiol
  doi: 10.1007/BF02821713
  contributor:
    fullname: Nguyen-Legros
– volume: 7
  start-page: 359
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0230
  article-title: A review of monoaminergic neuropsychopharmacology in zebrafish
  publication-title: Zebrafish
  doi: 10.1089/zeb.2010.0669
  contributor:
    fullname: Maximino
– volume: 32
  start-page: 424
  year: 1969
  ident: 10.1016/j.pbb.2012.12.010_bb0005
  article-title: Neurotransmission in central nervous tissue: a study of isolated rabbit retina
  publication-title: J Neurophysiol
  doi: 10.1152/jn.1969.32.3.424
  contributor:
    fullname: Ames
– volume: 20
  start-page: 923
  year: 2008
  ident: 10.1016/j.pbb.2012.12.010_bb0095
  article-title: Behavioral assay to measure responsiveness of zebrafish to changes in light increments and decrements
  publication-title: J Vis Exp
  contributor:
    fullname: Emran
– volume: 72
  start-page: 256
  year: 2012
  ident: 10.1016/j.pbb.2012.12.010_bb0330
  article-title: Dopaminergic and noradrenergic circuit development in zebrafish
  publication-title: Dev Neurobiol
  doi: 10.1002/dneu.20911
  contributor:
    fullname: Schweitzer
– volume: 327
  start-page: 348
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0305
  article-title: Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation
  publication-title: Science
  doi: 10.1126/science.1183090
  contributor:
    fullname: Rihel
– volume: 91
  start-page: 153
  year: 1983
  ident: 10.1016/j.pbb.2012.12.010_bb0165
  article-title: SCH 23390 - the first selective dopamine D-1 antagonist
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(83)90381-3
  contributor:
    fullname: Hyttel
– volume: 78
  start-page: 189
  year: 1998
  ident: 10.1016/j.pbb.2012.12.010_bb0245
  article-title: Dopamine receptors: from structure to function
  publication-title: Physiol Rev
  doi: 10.1152/physrev.1998.78.1.189
  contributor:
    fullname: Missale
– volume: 6
  start-page: 231
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0200
  article-title: Rapid behavior-based identification of neuroactive small molecules in the zebrafish
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.307
  contributor:
    fullname: Kokel
– volume: 49
  start-page: 943
  year: 2009
  ident: 10.1016/j.pbb.2012.12.010_bb0185
  article-title: Retinal parallel pathways: seeing with our inner fish
  publication-title: Vision Res
  doi: 10.1016/j.visres.2008.07.019
  contributor:
    fullname: Joselevitch
– volume: 44
  start-page: 9
  year: 2011
  ident: 10.1016/j.pbb.2012.12.010_bb0100
  article-title: Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2011.05.016
  contributor:
    fullname: Farrell
– volume: 167
  start-page: 480
  year: 1995
  ident: 10.1016/j.pbb.2012.12.010_bb0195
  article-title: Antipsychotic drug-induced dysphoria
  publication-title: Br J Psychiatry
  doi: 10.1192/bjp.167.4.480
  contributor:
    fullname: King
– volume: 2
  start-page: 37
  year: 1976
  ident: 10.1016/j.pbb.2012.12.010_bb0370
  article-title: 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome
  publication-title: Pharmacol Ther B
  contributor:
    fullname: Ungerstedt
– volume: 191
  start-page: S104
  issue: Suppl. 1
  year: 2005
  ident: 10.1016/j.pbb.2012.12.010_bb0390
  article-title: Development of the dopaminergic neurons in the rodent brainstem
  publication-title: Exp Neurol
  doi: 10.1016/j.expneurol.2004.05.044
  contributor:
    fullname: Vitalis
– volume: 28
  start-page: 245
  year: 2006
  ident: 10.1016/j.pbb.2012.12.010_bb0120
  article-title: Antipsychotics produce locomotor impairment in larval zebrafish
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/j.ntt.2006.01.013
  contributor:
    fullname: Giacomini
– volume: 98
  start-page: 245
  year: 1989
  ident: 10.1016/j.pbb.2012.12.010_bb0255
  article-title: Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/BF00444699
  contributor:
    fullname: Murray
– volume: 166
  start-page: 391
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0015
  article-title: Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2009.12.033
  contributor:
    fullname: Ardayfio
– volume: 22
  start-page: 2042
  year: 2012
  ident: 10.1016/j.pbb.2012.12.010_bb0105
  article-title: Deep brain photoreceptors control light-seeking behavior in zebrafish larvae
  publication-title: Curr Biol
  doi: 10.1016/j.cub.2012.08.016
  contributor:
    fullname: Fernandes
– volume: 43
  start-page: 507
  year: 1991
  ident: 10.1016/j.pbb.2012.12.010_bb0020
  article-title: Receptor subtype-specific dopaminergic agents and unconditioned behavior
  publication-title: Pol J Pharmacol Pharm
  contributor:
    fullname: Beninger
– volume: 30
  start-page: 6048
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0040
  article-title: Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.5094-09.2010
  contributor:
    fullname: Bowton
– volume: 131
  start-page: 301
  year: 1986
  ident: 10.1016/j.pbb.2012.12.010_bb0045
  article-title: Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(86)90588-1
  contributor:
    fullname: Braun
– year: 2011
  ident: 10.1016/j.pbb.2012.12.010_bb0260
  contributor:
    fullname: National Research Council
– volume: 6
  start-page: 155
  year: 2007
  ident: 10.1016/j.pbb.2012.12.010_bb0035
  article-title: D4 Dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour
  publication-title: Genes Brain Behav
  doi: 10.1111/j.1601-183X.2006.00243.x
  contributor:
    fullname: Boehmler
– volume: 30
  start-page: 188
  year: 2007
  ident: 10.1016/j.pbb.2012.12.010_bb0175
  article-title: Dopamine: 50years in perspective
  publication-title: Trends Neurosci
  doi: 10.1016/j.tins.2007.03.002
  contributor:
    fullname: Iversen
– volume: 42
  start-page: 753
  year: 2005
  ident: 10.1016/j.pbb.2012.12.010_bb0415
  article-title: Neuroanatomical phenotyping in the mouse: the dopaminergic system
  publication-title: Vet Pathol
  doi: 10.1354/vp.42-6-753
  contributor:
    fullname: Zeiss
– volume: 14
  start-page: 87
  year: 1996
  ident: 10.1016/j.pbb.2012.12.010_bb0055
  article-title: Radioreceptor binding profile of the atypical antipsychotic olanzapine
  publication-title: Neuropsychopharmacology
  doi: 10.1016/0893-133X(94)00129-N
  contributor:
    fullname: Bymaster
– volume: 137
  start-page: 89
  year: 2002
  ident: 10.1016/j.pbb.2012.12.010_bb0315
  article-title: Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study
  publication-title: Brain Res Dev Brain Res
  doi: 10.1016/S0165-3806(02)00354-1
  contributor:
    fullname: Rink
– volume: 20
  start-page: RC91
  year: 2000
  ident: 10.1016/j.pbb.2012.12.010_bb0420
  article-title: G(olf)alpha mediates dopamine D1 receptor signaling
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.20-16-j0001.2000
  contributor:
    fullname: Zhuang
– volume: 21
  start-page: 4390
  year: 2001
  ident: 10.1016/j.pbb.2012.12.010_bb0150
  article-title: Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-12-04390.2001
  contributor:
    fullname: Herve
– volume: 30
  start-page: 52
  year: 2009
  ident: 10.1016/j.pbb.2012.12.010_bb0225
  article-title: Locomotion in larval zebrafish: influence of time of day, lighting and ethanol
  publication-title: Neurotoxicology
  doi: 10.1016/j.neuro.2008.09.011
  contributor:
    fullname: MacPhail
– volume: 228
  start-page: 143
  year: 1985
  ident: 10.1016/j.pbb.2012.12.010_bb0130
  article-title: Neurobiological bases of rhythmic motor acts in vertebrates
  publication-title: Science
  doi: 10.1126/science.3975635
  contributor:
    fullname: Grillner
– volume: 258
  start-page: 910
  year: 1991
  ident: 10.1016/j.pbb.2012.12.010_bb0025
  article-title: Behavioral effects of D1 and D2 dopaminereceptor antagonists in squirrel monkeys
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Bergman
– volume: 27
  start-page: 13192
  year: 2007
  ident: 10.1016/j.pbb.2012.12.010_bb0145
  article-title: Dopaminergic modulation of spinal neuronal excitability
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.1279-07.2007
  contributor:
    fullname: Han
– volume: 133
  start-page: 233
  year: 1997
  ident: 10.1016/j.pbb.2012.12.010_bb0220
  article-title: The effects of haloperidol on visual search, eye movements and psychomotor performance
  publication-title: Psychopharmacology (Berl)
  doi: 10.1007/s002130050396
  contributor:
    fullname: Lynch
– volume: 1349
  start-page: 41
  year: 2010
  ident: 10.1016/j.pbb.2012.12.010_bb0235
  article-title: Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy
  publication-title: Brain Res
  doi: 10.1016/j.brainres.2010.06.020
  contributor:
    fullname: Melo
– volume: 115
  start-page: 677
  year: 2008
  ident: 10.1016/j.pbb.2012.12.010_bb0205
  article-title: The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats
  publication-title: J Neural Transm
  doi: 10.1007/s00702-007-0009-0
  contributor:
    fullname: Kolasiewicz
– volume: 11
  start-page: 421
  year: 1989
  ident: 10.1016/j.pbb.2012.12.010_bb0250
  article-title: Acute exposure to maneb alters some behavioral functions in the mouse
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/0892-0362(89)90018-4
  contributor:
    fullname: Morato
– volume: 60
  start-page: 163
  year: 1979
  ident: 10.1016/j.pbb.2012.12.010_bb0290
  article-title: Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway
  publication-title: Eur J Pharmacol
  doi: 10.1016/0014-2999(79)90215-2
  contributor:
    fullname: Oberlander
– volume: 224
  start-page: 135
  year: 2011
  ident: 10.1016/j.pbb.2012.12.010_bb0335
  article-title: Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio)
  publication-title: Behav Brain Res
  doi: 10.1016/j.bbr.2011.05.034
  contributor:
    fullname: Seibt
– volume: 236
  start-page: 1339
  year: 2007
  ident: 10.1016/j.pbb.2012.12.010_bb0210
  article-title: Cloning and spatial and temporal expression of the zebrafish dopamine D1 receptor
  publication-title: Dev Dyn
  doi: 10.1002/dvdy.21130
  contributor:
    fullname: Li
SSID ssj0004267
Score 2.4751244
Snippet Altered dopaminergic signaling causes behavioral changes in mammals. In general, dopaminergic receptor agonists increase locomotor activity, while antagonists...
SourceID pubmedcentral
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 792
SubjectTerms Acute
Animals
Dopamine
Dopamine Agents - administration & dosage
Dopamine Agonists - administration & dosage
Dopamine Antagonists - administration & dosage
Dose-Response Relationship, Drug
Larva - drug effects
Larva - physiology
Locomotor activity
Models, Animal
Motor Activity - drug effects
Motor Activity - physiology
Receptor
Receptors, Dopamine - physiology
Zebrafish
Zebrafish - physiology
Title Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish
URI https://dx.doi.org/10.1016/j.pbb.2012.12.010
https://www.ncbi.nlm.nih.gov/pubmed/23274813
https://pubmed.ncbi.nlm.nih.gov/PMC3640837
Volume 103
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB4huHBBCwtsgUU-rDigBpLYsZNjhUDdRVQ9gNRb5Oc2CNqKtody4LfvOI92c1mklXLJw4rlsT7P2N98A_CDa265ZmHAdCwwQDE8SGUYBtaFWahoLDPrA8WHAe8_sV-jZLQFN00ujKdV1thfYXqJ1vWT63o0r2dF4XN8MwTgRESeX0WZl91mSeirGFx9bGgeuALVupl-nyURzclmyfGaKeXZXXG5I-iTaD9Zm9q8yb8WorsvsFd7kKRXdXIftuzkAC6GlQT1qkseNxlV8y65IMONOPXqAHbXiLf6CranlwtLZEtAl0wdMRhKv5ZpgYUm5m35e07Gck6aaiqICi-kZoIQbIEL4rQqB0QKvPPlhl7Iuz-SdsV8fAhPd7ePN_2grrsQ6CQSi8BxyjHOkYlT1BinE2mi2JiQoy_CI5mlRmhlBfqSKUaXqZJRYmmkGZXMOSUoPYLtyXRivwGhNmYqdLFwTjAlXEpZ6kTmpNYYi2rVgctmxPNZJa-RN7yz5xzNk3vz5HiheTrAGpvkrTmSI_z_q9lxZbb1H9CLFCyNaAdEy6DrD7zmdvvNpBiX2tuUM3Raxcn_deUUduOynIanw5zB9uJtab-jU7NQ5-WsPYed3s_7_uAPB-f5fQ
link.rule.ids 230,314,780,784,885,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB7R9FAuFdDSpjy6B8ShwmB717v2MUKglJc4BImbtc_GFU0ikhzCgd_OrB8JvoBUyRc_Vl7tjOax-803AAdcc8s1CwOmY4EJiuFBKsMwsC7MQkVjmVmfKF7f8P4du7hP7tfgtKmF8bDK2vZXNr201vWTk3o1TyZF4Wt8MzTAiYg8vooy_gE-sgSjX1Tq4-cVzgNdUE2c6TdaEtEcbZYgr4lSHt4Vl1uCvor2HefUBk6-8kTnG_C5DiFJr5rlJqzZ0RYc3lYc1IsjMliVVE2PyCG5XbFTL7ZgfWnyFl_A9vR8ZolsMeiSsSMGc-l_ZV1goYl5nP-ZkqGckqadCpqFB1JDQQiOQI84rvoBkQLvfL-hB_Lkz6RdMR1-hbvzs8FpP6gbLwQ6icQscJxyTHRk4hQ1xulEmig2JuQYjPBIZqkRWlmBwWSK6WWqZJRYGmlGJXNOCUq3oTMaj-x3INTGTIUuFs4JpoRLKUudyJzUGpNRrbrwq1nxfFLxa-QN8OxvjuLJvXhyvFA8XWCNTPKWkuRo_98a9q0S2_IPGEYKlka0C6Il0OUHnnS7_WZUDEvybcoZRq3ix_9N5Sd86g-ur_Kr3zeXO7Ael701PDZmFzqzx7ndwwhnpvZLDX4B3Iv7Gg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acute+administration+of+dopaminergic+drugs+has+differential+effects+on+locomotion+in+larval+zebrafish&rft.jtitle=Pharmacology%2C+biochemistry+and+behavior&rft.au=Irons%2C+T.D.&rft.au=Kelly%2C+P.E.&rft.au=Hunter%2C+D.L.&rft.au=MacPhail%2C+R.C.&rft.date=2013-02-01&rft.pub=Elsevier+Inc&rft.issn=0091-3057&rft.eissn=1873-5177&rft.volume=103&rft.issue=4&rft.spage=792&rft.epage=813&rft_id=info:doi/10.1016%2Fj.pbb.2012.12.010&rft.externalDocID=S0091305712003346
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-3057&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-3057&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-3057&client=summon